» Articles » PMID: 39479990

The Circulating Proteome─Technological Developments, Current Challenges, and Future Trends

Abstract

Recent improvements in proteomics technologies have fundamentally altered our capacities to characterize human biology. There is an ever-growing interest in using these novel methods for studying the circulating proteome, as blood offers an accessible window into human health. However, every methodological innovation and analytical progress calls for reassessing our existing approaches and routines to ensure that the new data will add value to the greater biomedical research community and avoid previous errors. As representatives of HUPO's Human Plasma Proteome Project (HPPP), we present our 2024 survey of the current progress in our community, including the latest build of the Human Plasma Proteome PeptideAtlas that now comprises 4608 proteins detected in 113 data sets. We then discuss the updates of established proteomics methods, emerging technologies, and investigations of proteoforms, protein networks, extracellualr vesicles, circulating antibodies and microsamples. Finally, we provide a prospective view of using the current and emerging proteomics tools in studies of circulating proteins.

Citing Articles

Mass-spectrometry-based proteomics: from single cells to clinical applications.

Guo T, Steen J, Mann M Nature. 2025; 638(8052):901-911.

PMID: 40011722 DOI: 10.1038/s41586-025-08584-0.


Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium.

Albrecht V, Muller-Reif J, Nordmann T, Mund A, Schweizer L, Geyer P Mol Cell Proteomics. 2024; 23(12):100877.

PMID: 39522756 PMC: 11652764. DOI: 10.1016/j.mcpro.2024.100877.

References
1.
Kotol D, Woessmann J, Hober A, Alvez M, Tran Minh K, Ponten F . Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma. Cancers (Basel). 2023; 15(19). PMC: 10571728. DOI: 10.3390/cancers15194764. View

2.
Oh H, Rutledge J, Nachun D, Palovics R, Abiose O, Moran-Losada P . Organ aging signatures in the plasma proteome track health and disease. Nature. 2023; 624(7990):164-172. PMC: 10700136. DOI: 10.1038/s41586-023-06802-1. View

3.
Bauer W, Weber M, Diehl-Wiesenecker E, Galtung N, Prpic M, Somasundaram R . Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection. Viruses. 2021; 13(12). PMC: 8706135. DOI: 10.3390/v13122456. View

4.
Ramazi S, Zahiri J . Posttranslational modifications in proteins: resources, tools and prediction methods. Database (Oxford). 2021; 2021. PMC: 8040245. DOI: 10.1093/database/baab012. View

5.
Deutsch E, Bandeira N, Perez-Riverol Y, Sharma V, Carver J, Mendoza L . The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res. 2022; 51(D1):D1539-D1548. PMC: 9825490. DOI: 10.1093/nar/gkac1040. View